Kazia Therapeutics Ltd (KZIA)
0.272
-0.01
(-3.72%)
USD |
NASDAQ |
May 03, 16:00
0.277
0.00 (0.00%)
Pre-Market: 20:00
Kazia Therapeutics Cash from Operations (TTM): -8.366M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -8.366M |
June 30, 2023 | -10.03M |
December 31, 2022 | -9.778M |
June 30, 2020 | -5.861M |
December 31, 2019 | -3.517M |
June 30, 2019 | -4.774M |
December 31, 2018 | -3.735M |
June 30, 2018 | -6.641M |
December 31, 2017 | -8.847M |
June 30, 2017 | -8.577M |
December 31, 2016 | -8.699M |
June 30, 2016 | -8.725M |
December 31, 2015 | -9.119M |
Date | Value |
---|---|
June 30, 2015 | -4.591M |
December 31, 2014 | -4.625M |
June 30, 2014 | -5.313M |
December 31, 2013 | -3.198M |
June 30, 2013 | -9.073M |
December 31, 2012 | -13.03M |
June 30, 2012 | -7.425M |
December 31, 2011 | -5.986M |
June 30, 2011 | -8.863M |
December 31, 2010 | -10.04M |
June 30, 2010 | -14.95M |
December 31, 2009 | -17.12M |
June 30, 2009 | -14.65M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-10.03M
Minimum
Jun 2023
-3.517M
Maximum
Dec 2019
-7.054M
Average
-7.113M
Median
Cash from Operations (TTM) Benchmarks
Immutep Ltd | -- |
Opthea Ltd | -- |
Alterity Therapeutics Ltd | -10.07M |
Mesoblast Ltd | -63.27M |
Immuron Ltd | -- |